DEMAND for probiotics in China is attracting many companies to enter the lucrative market. As an innovator in the field of microbiome, ADM offers a series of diversified health microbiome innovations covering digestive health, immune health, and metabolic health. Most of these were featured at the 2024 Asia Natural and Nutraceutical Products Exhibition (HNC 2024) under the theme of "Future Nutrition, Science Empowered". At this event, Ms. Helen Hu, President of ADM Health Business Unit Asia Pacific, talked about the current situation and challenges in the probiotics market and shared the future development strategy of the company. Ms. Helen Hu, President of ADM Health Business Unit Asia Pacific Breakthrough products demonstrate ADM's strength in scientific research At HNC 2024, ADM launched the newly approved spore-based probiotic DE111, which is the first Bacillus subtilis strain approved by the National Health Commission of China. "DE111 exhibits shelf...